Trial intelligence / Profile preview

Benzocaine 20% for Pain Control in Hall Technique Separator Placement

NCT06272903Phase 1Completed

Sponsor
Mohammed Bin Rashid University of Medicine and Health Sciences
Start
Apr 2024
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, single-blind trial in procedural pain comparing Benzocaine 20% with Placebo (2 arms). Primary endpoint: Immediate Pain Levels. Started Apr 2024; status: completed.

02

Drugs

benzocaine
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT06272903.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06272903.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call